Advertisement
Neurology
Subscribe to Neurology
View Sample

FREE Email Newsletter

Lower Extremity Functional Electrical Stimulation Cycling Promotes Physical & Neurological Recovery in Chronic Spinal Cord Injury

March 4, 2013 2:27 pm | by Bio-Medicine.Org | News | Comments

BALTIMORE , March 4, 2013 /- A new study by Kennedy Krieger Institute's International Center for Spinal Cord Injury (Epub ahead of print) finds that long-term lower extremity functional electrical stimulation (FES) cycling, as part of a rehabilitation regimen, is associated with substantial improvements in individuals with chronic spinal cord injury (SCI).

Five Psychiatric Disorders Share Genetic Risk Factors

February 28, 2013 4:01 pm | by Massachusetts Institute of Technology | News | Comments

Five different psychiatric illnesses share a handful of genetic risk factors, report researchers in The Lancet. Four DNA mutations were discovered in the genomes of people who had at least one of five distinct disorders: attention deficit-hyperactivity disorder, autism, bipolar disorder, major depressive disorder and schizophrenia.

Neuro Kinetics Adds Software, Engineering Professionals as Push Continues for Improved Testing of Battlefield Concussions

February 28, 2013 9:48 am | by The Associated Press | News | Comments

Medical diagnostic device manufacturer Neuro Kinetics, Inc. said today that it has added five software and engineering professionals to its staff as the company continues to develop new testing protocols for diagnosis of concussions and other brain injuries. ...

Advertisement

Rats Communicate Through Brain Chips

February 28, 2013 9:00 am | by Massachusetts Institute of Technology | News | Comments

Pairs of rats can communicate through brain chips and collaborate to perform a task, report researchers in today’s Scientific Reports. Brain activity recorded in one rat was translated into a pattern of electrical pulses that were then transmitted to another rat that had been trained to push a particular lever in response to one of two patterns of electrical stimulation in its brain.

Cognoptix begins pre-pivotal clinical trial of its drug/device test designed to identify Alzheimer’s disease via beta amyloid signature in the eyes

February 28, 2013 8:30 am | by The Associated Press | News | Comments

ACTON, Mass.--(BUSINESS WIRE)--Feb 28, 2013--Cognoptix announced today that it has begun a 40-patient clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer’s disease patients via a beta amyloid (“Ab”) signature in their eyes. By detecting a specific fluorescent signature of...

FDA Advisory Panel Recommends Approval of the NeuroPace RNS® System for Medically Refractory Epilepsy

February 26, 2013 8:00 am | by The Associated Press | News | Comments

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Feb 26, 2013--NeuroPace, Inc. today announced that on February 22, 2013 the U.S. Food and Drug Administration (FDA) Neurological Devices Panel voted unanimously (11 to 0 with two abstentions) that the clinical benefits of the NeuroPace RNS System outweigh...

Brain Implants Can Reset Misfiring Circuits

February 25, 2013 3:39 pm | by Massachusetts Institute of Technology | News | Comments

A study that combined electrical stimulation of the brain with advanced imaging has shown how correcting misfiring neural circuits can lessen the symptoms of a common psychiatric disorder. A brain-pacemaker helped put out-of-sync brain circuits back on track in patients with extreme forms of obsessive-compulsive disorder.

Implanted Electrodes Can Help Amputees Gain Sensation in Prosthetics

February 25, 2013 7:29 am | by Mass Device | News | Comments

Swiss researchers have a developed a new prosthetic limb system that uses implanted electrodes to send sensory signals from the limb back to the brain, creating a more realistic sense of touch. "We could be on the cusp of providing new and more effective clinical solutions to amputees in the next years," Silvestro Micera, head engineer...

Advertisement

FDA Panel Recommends Approval of Neuropace's Anti-Epilepsy Implant

February 22, 2013 6:33 pm | by Mass Device | News | Comments

California neurostimulation devices maker NeuroPace crept 1 step closer to an FDA win for its epilepsy implant with near-unanimous approval from the FDA's Neurological Devices Advisory Panel. The expert panelists today voted unanimously that the RNS implantable neurostimulator demonstrated safety in clinical trials...

NMMC Physicians Implant State's First Vagal Nerve Stimulator for Heart Failure

February 21, 2013 3:39 pm | by The Associated Press | News | Comments

Doctors at North Mississippi Medical Center recently implanted the state's first vagal nerve stimulator as part of a clinical research study to treat heart failure through nerve stimulation in the neck. According to cardiac electrophysiologist Karl Crossen, M.D., and neurosurgeon Louis...

Integrated Implant Makes It Easier to Control the Brain with Light

February 20, 2013 10:15 am | by IEEE Spectrum | News | Comments

Almost a decade ago, Stanford University researchers jump-started a new field of study when they genetically altered brain cells, shone light on them, and demonstrated that they could control the modified neurons. This brain-control technique, called optogenetics, has since taken off at labs around the world and could lead to breakthroughs for Parkinson’s disease...

Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center

February 20, 2013 9:15 am | by The Associated Press | News | Comments

Neuralstem, Inc. (NYSE MKT: CUR) announced that it has granted licenses to intellectual property surrounding its spinal cord delivery platform, floating cannula, and method for delivering therapeutic agents to the spinal cord to Cedars-Sinai Medical Center, a non-profit academic medical ...

Monitoring Concussions from the Sidelines with a Mobile App

February 18, 2013 7:29 am | by Mass Device | News | Comments

Massachusetts researchers developed a smartphone app that doctors may be able to use to monitor neurological activity on the go. The app may make a big splash among sports doctors who need to keep an eye on the health of athletes at risk of traumatic brain injury.

Advertisement

Consistently Good Acute Stroke Outcomes and Device Safety With The Penumbra System™ Again Confirmed In NIH-Funded Study

February 13, 2013 1:41 pm | by The Associated Press | News | Comments

ALAMEDA, Calif.--(BUSINESS WIRE)--Feb 13, 2013--Last week Joseph Broderick, MD, Principle Investigator of the Interventional Management Of Stroke III (IMS III) Trial, announced the overall results and major subgroup analyses at the International Stroke Conference (ISC) in Honolulu, Hawaii.

NeuroSigma Invited to Present an Overview of eTNS for the Treatment of Epilepsy and Depression at The Royal Society of Medicine in London

February 11, 2013 3:19 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES , Feb. 11, 2013 /- NeuroSigma, Inc., a California -based medical device company, today announced that Christopher DeGiorgio , M.D., Vice President of Neurology at NeuroSigma and Professor of Neurology at the University of California, Los Angeles (UCLA), and Colin Kealey , M.D., Manager of Business Development at NeuroSigma, will present in London , an over...

Pitt/UPMC Team Describes Technology that Lets Spinal Cord-Injured Man Control Robot Arm with Thoughts

February 8, 2013 1:44 pm | by University of Pittsburgh School of Medicine | News | Comments

Researchers at the University of Pittsburgh School of Medicine and UPMC describe in PLoS ONE how an electrode array sitting on top of the brain enabled a 30-year-old paralyzed man to control the movement of a character on a computer screen in three dimensions with just his thoughts. It also enabled him to move a robot arm to touch a friend’s hand for the first time in the seven years.

Effective Drug-free Treatment for Migraine Published in NEUROLOGY

February 7, 2013 10:34 am | by PR Newswire | News | Comments

LIEGE, Belgium, February 7, 2013 /PRNewswire/ -- The American scientific journal NEUROLOGY publishes the positive results of the PREMICE clinical study on the effectiveness and safety of the CEFALY® medical device in the prevention of migraine. NEUROLOGY (official journal of the...

$1,000,000 Global B.R.A.I.N. Prize Seeks Applicants

February 6, 2013 10:08 am | by PR Newswire | News | Comments

TEL AVIV, Israel, February 6, 2013 /PRNewswire/ -- Israel Brain Technologies (IBT) is seeking applicants for its $1,000,000 Global B.R.A.I.N. Prize competition. Applications will be accepted until March 15, 2013. The Global B.R.A.I.N (Breakthrough Research And Innovation in...

ZOLL Receives Shonin Approval from Japan to Market Intravascular Temperature Management Technology

February 6, 2013 12:05 am | by The Associated Press | News | Comments

CHELMSFORD, Mass.--(BUSINESS WIRE)--Feb 6, 2013--ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to enter the Japanese market with its Intravascular Temperature...

GE Healthcare and NFL team up to fight sports-related brain injuries

February 5, 2013 3:20 pm | by Mass Device | News | Comments

Health technology giant GE Healthcare joins forces with the National Football Assn. to develop concussion detection systems and brain protection technologies to make football a safer sport. Technology giant GE (NYSE:GE) announced a new partnership with the National Football Assn. in pursuit of better concussion detection technology and materials that may better protect athletes from traumatic brain injuries.

ATI Neurostimulation System Shown to be Highly Effective in Treating Cluster Headache

February 5, 2013 2:00 am | by The Associated Press | News | Comments

Autonomic Technologies, Inc. (ATI), the developer of the ATI Neurostimulation System designed for the treatment of severe headaches, today announced results of their clinical study in cluster headache, now published online. The robust, multi-centre, randomized, placebo-controlled clinical study is the largest study performed with a medical device for cluster headache.

Cyberonics Announces Update On Hagerty Lawsuit

February 4, 2013 11:23 am | by PR Newswire | News | Comments

HOUSTON, Feb. 4, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced that the lawsuit filed by former employee Andrew Hagerty in federal district court in Massachusetts was voluntarily dismissed without prejudice by Mr. Hagerty on February 1, 2013. 

Penumbra Inc. Launches 5MAX DDC™ and 4MAX DDC™ Distal Delivery Catheters

February 4, 2013 8:00 am | by The Associated Press | News | Comments

The Penumbra 5MAX DDC and 4MAX DDC distal delivery catheters are new devices designed to simplify delivery of a wide variety of endovascular therapies to the brain. The DDC family delivers exceptional distal delivery capability via a novel advanced polymer and nitinol coil reinforcement design at the distal tip to enable easy tracking through tortuous vessels.

Watching Fish Thoughts Form

February 1, 2013 4:14 pm | by Massachusetts Institute of Technology | News | Comments

Scientists record the neuronal activity of a fish brain as the animal watches its prey. Scientists in Japan have recorded the neuronal activity of a fish as it eyes its dinner, the first live recording of the brain processes behind a natural behavior. The study was published online in Current Biology on Thursday.

New Tool to Help Brain Surgeons, One Step Closer to Operating Room

January 10, 2013 9:44 am | by Purdue University | News | Comments

A new tool that could allow for faster, more comprehensive testing of brain tissue during surgery successfully identified the cancer type, grade and tumor margins in five brain surgery patients, according to a Purdue University and Brigham and Women's Hospital study.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading